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Background: The patient's right to be involved in treatment decisions is anchored in 
guidelines and legislation in many countries. Previous research suggests challenges 
in the implementation of user involvement across different areas of health care, in-
cluding mental health. However, little is known about psychiatric outpatients’ experi-
ences of being involved in their treatment.
Objective: To investigate how psychiatric outpatients after treatment rate the de-
gree to which they were included in the treatment and explore the associations be-
tween perceived user involvement, demographic characteristics of the sample and 
patient satisfaction.
Design: Cross-sectional.
Setting and participants: The sample consisted of 188 psychiatric outpatients (67% 
female, mean age 42.2 years) who were discharged in the two years prior to data 
collection.
Main variables studied: Perceived user involvement in psychiatric outpatient treat-
ment and patient satisfaction as measured by the Psychiatric Out-Patient Experiences 
Questionnaire.
Results: About half of the participants rated the overall degree of involvement in 
their treatment as high or very high. The lowest percentage of participants reporting 
high or very high involvement was found for sufficient information to contribute to 
treatment decisions (36%). Female gender, higher education and, to a small degree, 
younger age were associated with more involvement. Perceived user involvement 
was strongly associated with treatment satisfaction.
Discussion and conclusion: The findings suggest that user involvement in psychiatric 
outpatient treatment can be improved. Patient information that facilitates user in-
volvement should be given more attention.
Patient or Public Contribution: The hospital's user panel was involved in the develop-
ment of items assessing user involvement.
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1  | INTRODUC TION
Promoted by the World Health Organization and anchored in the 
legislation of many Western countries, user involvement is empha-
sized in the provision of contemporary mental health care.1,2 This 
emphasis marks a shift from paternalistic to partnership-oriented 
models of the relationship between the health-care provider and the 
patient, in which both parts contribute with their expertise and ex-
perience on equal terms to achieve desired outcomes.3,4
In Norway, user involvement emerged as a central concept in 
health policy documents in the 1990s. In these documents, it is ar-
gued that the inclusion of the users’ experiences and knowledge is 
a value in itself and that it has a therapeutic effect and improves 
the quality of health services.5 In the Patient Right Act6 and the 
Specialized Health Care Act,7 among others, the patient's right to be 
involved in treatment decisions and the health-care service's obliga-
tion to include patients in individual treatment planning and service 
evaluation are legally defined.
Although it is widely acknowledged that user involvement is an 
integral part of providing mental health-care services, consensus 
about the definition of user involvement has not been reached. A 
variety of definitions of user involvement in mental health care has 
been suggested in the research literature.8 For example, Tambuyzer 
et al9 identified participation in decision making, active character 
of involvement (as opposed to being a passive recipient of infor-
mation), involvement in a diverse range of activities (eg treatment, 
evaluation, research, training), expertise by lived experience and 
collaboration with professionals as key elements of user involve-
ment in mental health. Similarly, Millar et al8 proposed that user 
involvement in mental health care has five defining attributes: a 
person-centred approach, informed decision making, advocacy, ob-
taining service user views and feedback, and working in partnership. 
Accordingly, Millar et al defined user involvement in mental health 
services as 'an active partnership between service users and men-
tal health professionals in decision making regarding the planning, 
implementation and evaluation of mental health policy, services, 
education, training and research. This partnership employs a per-
son-centered approach, with bidirectional information flow, power 
sharing and access to advocacy at a personal, service and/or societal 
level'.8 As stated in this definition, user involvement can occur in 
different areas and on different levels. Tambuyzer et al9 suggested 
four organizational levels in which user involvement is relevant: the 
individual patient (micro level), the health-care service or the insti-
tution (meso level), mental health politics (macro level), and training 
and research (meta level).
However, although user involvement has become a legal stan-
dard internationally, research suggests that user involvement in 
mental health care is currently not fully realized in many coun-
tries,10,11 including Norway.12 Bee et al10 identified poor information 
exchange between the health service and the user as the main cause 
for the lack of user involvement. Obviously, mental health profes-
sionals have a central role in facilitating user involvement. In general, 
mental health professionals have positive attitudes towards user in-
volvement.13-16 However, differences between professional groups 
have been noted, with social workers and psychiatric nurses tending 
to be more open to user involvement in mental health care than psy-
chiatrists and psychologists.17 In addition, professionals working in 
outpatient care have shown more positive attitudes towards user 
involvement than professionals working in inpatient care.14 Lack 
of insight, difficulties with collaboration during episodes of severe 
mental illness, limited availability of the user's preferences and at-
titudes within mental health services perceived as disempowering 
the staff and users have been reported as potential obstacles to user 
involvement by professionals.16,18-20
Despite slow progress in implementing user involvement on 
the organizational level and expressed concerns by service users 
about tokenism,21 study findings suggest that patients are gen-
erally interested in being involved in mental health services,13,22 
particularly with regard to their own treatment.23,24 On the other 
hand, it has been observed that patients with severe mental ill-
ness preferred a more passive role in medical decision making than 
non-psychiatric controls.25 However, although benefits of user 
involvement in mental health care for the individual patient are 
commonly assumed, research into the associations of user involve-
ment with treatment outcomes on the individual level is scarce 
and inconclusive.26 For example, in Omeni et al's study,13 service 
providers and service users reported a positive impact of user in-
volvement activities on self-esteem and recovery. Tambuyzer and 
Van Audenhove27 found that user involvement is associated with 
patient satisfaction and increased empowerment. Nevertheless, 
despite encouraging findings, the evidence base is currently 
weak.26,28
Most research on user involvement in mental health services has 
been conducted in inpatient settings, and little is known about the 
experiences of outpatients when it comes to participation in treat-
ment decisions. The present study therefore aimed to investigate 
how psychiatric outpatients, after treatment, rate the degree to 
which they were included in different aspects of the treatment and 
whether perceived user involvement is related to the demographic 
background and the kind of treatment they had received. A second 
goal of the current investigation was to examine the associations be-
tween user involvement and treatment satisfaction in terms of the 
quality of clinical interaction, information provision and treatment 
outcome.
K E Y W O R D S
mental health, outpatient treatment, patient satisfaction, psychiatry, shared decision making, 
user involvement
     |  3THIMM eT al.
2  | METHODS
2.1 | Participants and procedures
Psychiatric outpatients who were discharged from treatment at the 
Psychiatric Centre of the Helgeland Hospital Trust in Mo i Rana in 
Norway in the two years prior to data collection in May 2017 were 
invited to participate in the present investigation. Patients were dis-
charged because they finished treatment or dropped out. We ap-
proached patients who were discharged instead of patients who 
were currently in treatment because the former group had expe-
rienced the complete course of therapy and was therefore able to 
answer questions about user involvement in all phases of treatment, 
including termination, which we deemed an important area for user 
involvement in mental health care. A total of 1048 eligible patients 
were identified using the clinics electronic health record system. 
Mail addresses were lacking for 13 patients. Thus, the questionnaire 
containing the study measures was mailed to 1035 patients. In an 
accompanying letter, the recipients were informed about the pur-
pose of the study, the researchers, voluntary participation and how 
to provide informed consent (by returning the questionnaire to the 
researchers). Participants were asked for permission to obtain their 
diagnosis from the electronic records. One reminder was sent after 
approximately three weeks. One hundred and eighty-nine patients 
returned the questionnaire, which corresponds to a response rate 
of 18.3%. One participant reported in the comment field at the end 
of the questionnaire to never have been in treatment at the out-
patient clinic and was thus excluded from the analyses. The final 
sample comprised 188 participants (67% female) with a mean age 
of 42.2 years (SD = 14.8 years, range 19 to 84 years). Additional 
demographic and clinical information about the sample is provided 
in Table 1.
Prior to the study, ethical approval was applied for from the 
Regional Committee for Medical and Health Research. The com-
mittee decided that approval from this entity was not required for 
the present investigation. The Norwegian Data Protection Service 
(NSD) was notified about the study (ref. nr 50690).
2.2 | Measures
User involvement in psychiatric outpatient treatment was assessed 
with six self-report items that cover different aspects of psychiat-
ric outpatient treatment: (a) overall user involvement in treatment; 
(b) a say in the treatment package; (c) evaluation of sessions dur-
ing treatment; (d) formulation of treatment goals; (e) termination of 
treatment; and (f) sufficient information to contribute to treatment 
decisions. The items were rated on a 5-point scale from 'not at all' (0) 
to 'to a very high degree' (4). Item 2 was taken from the Psychiatric 
Out-Patient Experiences Questionnaire.29 The remaining five items 
were developed for the present investigation because we were not 
aware of an existing measure of user involvement in psychiatric 
outpatient treatment. The items were selected based on previous 
research on user experiences in mental health care30 and a national 
policy document on user involvement in mental health care.5 The 
user panel of the hospital was involved in the process of item de-
velopment and commented on the questionnaire. This procedure 
ensured the face validity of the items. The six items were combined 
to form a user involvement scale. A confirmatory factor analysis 
was conducted in Mplus 8.431 using WLSMV estimation to test 
for the unidimensionality of the scale. The Comparative Fit Index 
(CFI), the Tucker Lewis Index (TLI) and the Standardized Root Mean 
Square Residual (SRMR) were used to assess model fit. The results 
(CFI = 0.99, TLI = 0.98, SRMR = 0.03) supported the proposed uni-
dimensionality of the scale when Hu and Bentler's32 cut-off values 
for good fit (CFI and TLI ≥ 0.95, and SRMR ≤ 0.08) are applied. The 
internal consistency of the scale was high (Cronbach's alpha = 0.90).
Treatment satisfaction was assessed with the Psychiatric Out-
Patient Experiences Questionnaire (POPEQ).29 The POPEQ is a 
self-report measure consisting of 11 items that are answered on 
a 5-point scale from 'not at all' (0) to 'to a very high degree' (4). In 
addition to an overall experience score, three subscale scores can 
be obtained: quality of clinical interaction (six items), information 
provision (two items), and outcome of the treatment (three items). 
Adequate-to-excellent psychometric properties have been reported 
for the POPEQ.29,33 In the present study, the item of the POPEQ 
that was used in the user involvement scale was omitted when the 
quality of clinical interaction scale and the POPEQ total score were 
calculated. In the current sample, the POPEQ scales showed high 
internal consistencies with Cronbach's alphas ranging from 0.83 (in-
formation provision) to 0.95 (total score).
2.3 | Statistical analyses
To examine the participants’ perception of user involvement in 
their treatment, the means, standard deviations and frequen-
cies of the response options for the six user involvement items 
were calculated. Mean item scores were obtained for the user 
involvement total score and the POPEQ scales. The associations 
between user involvement and the gender and age of the par-
ticipants were investigated with t tests and bivariate correla-
tions, respectively. To test the relationships between treatment 
mode and user involvement, t tests were conducted. The associa-
tions of education level with user involvement were investigated 
by means of ANOVAs. When collecting the data, it was aimed 
at recruiting at least 150 patients to be able to detect small-to-
medium effects in the correlation analyses with a power of 0.80 
and at a significance level of P < .05 based on Cohen's34 crite-
ria. No a priori power analysis was performed for comparisons of 
demographic groups with respect to user involvement. The final 
sample size of N = 188 exceeded the goal of 150 participants. A 
power analysis conducted with the pwr package35 in R 3.6.236 
showed that the group sizes were sufficient to detect medium ef-
fects (power = 0.80, α = 0.05) when examining perceived user in-
volvement in relation to gender, educational level (provided that 
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the two groups with university/college education were combined) 
and treatment mode (except for individual treatment). However, 
the number of participants in the different diagnostic categories 
was too small for an examination of the relationship between user 
involvement and diagnosis (ie only very large effects could have 
been detected with a power of 0.80 and an α of 0.05). Because 
the number of missing data points (4.5%) was within the range 
where multiple imputation provides negligible benefit,37 missing 
data were not replaced. Scale scores were computed for the user 
involvement scale, as were the POPEQ total and quality of clinical 
interaction scales when at least 80% of the items were answered. 
Due to the small number of items that constitute the POPEQ in-
formation provision (2 items) and outcome (3 items) scales, all 
items had to be answered in order to be included in the analyses. 
Computation of Cronbach's alpha, descriptive statistics, correla-
tions and comparisons of group means were performed in IBM 
SPSS Statistics 26.
3  | RESULTS
The means, standard deviations, and response frequencies of the six 
user involvement items are displayed in Table 2. Results showed that 
54.8% of the participants rated the overall degree of involvement 
in their treatment as 'high' or 'very high'. For user involvement in 
the specific elements of outpatient treatment, the percentages of 
perceived involvement for 'to a high degree' or 'to a very high de-
gree' were 47.3% for formulation of treatment goals, 45.3% for a say 
in the treatment package, 43.1% for evaluation of sessions, 36.7% 
for termination of treatment, and 35.6% for sufficient information to 
participate in decision making.











More than 12 100 (53.2)
Treatment mode
Medication 68 (36.2)
Individual sessions 173 (92.0)
Group sessions 52 (27.7)
Sessions with family members 19 (10.1)




Neither married nor cohabitating 86 (45.7)
Educational level
Primary education 43 (22.9)
Upper secondary education 77 (41.0)
College/university less than 4 y 53 (28.2)




Another Nordic language 1 (0.5)
Another European language 2 (1.1)
Non-European language 4 (2.1)
Housing situation
Live alone 57 (30.3)
Live with children 51 (27.1)
Live with partner 97 (51.6)
Live with parents, siblings, others 12 (6.4)




On sick leave 9 (4.8)
Disability benefit recipient 45 (23.9)






Bipolar affective disorders (F31) 11 (5.9)
Depressive episode (F32) 18 (9.6)
Recurrent depressive disorder (F33) 20 (10.6)
Phobic anxiety disorders (F40) 13 (6.9)
Other anxiety disorders (F41) 12 (6.4)
Reaction to severe stress and adjustment 
disorders (F43)
23 (12.2)
Hyperkinetic disorders (F90) 10 (5.3)
Other diagnoses (eg mental and behavioural 
disorders due to psychoactive substance 
use, persistent mood disorders, somatoform 
disorders, eating disorders, personality 
disorders and general psychiatric 
examination)
65 (34.6)
No diagnosis 16 (8.5)
Note.: Due to missing data points and multiple responses, the summed 
values of a category may fall below or exceed N = 188 or 100%.
TA B L E  1   (Continued)
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The mean of the total score for the user involvement scale was 
2.27 (SD = 0.94; range 0–4). With respect to the associations be-
tween the demographic characteristics of the sample and the user 
involvement scale score, there was a significant negative association 
with age (r = −0.16, P = .034). Women (M = 2.38, SD = 0.88) reported 
a higher degree of user involvement than men (M = 2.00, SD = 0.99, 
t(177) = −2.62, P = .010, d = 0.41). Educational level was related to user 
involvement, F(2, 175) = 6.75, P = .001, η2 = 0.07. Post hoc tests (LSD) 
revealed that participants with primary education had lower scores 
on the user involvement scale (M = 1.82, SD = 1.08) compared to 
participants with college/university education (M = 2.46, SD = 0.85) 
and upper secondary education (M = 2.35, SD = 0.85) (all Ps < 0.01).
The results of the analyses that tested the associations between 
treatment mode and user involvement are shown in Table 3. The 
only treatment mode that was significantly related to user involve-
ment was a training programme to cope with symptoms. The asso-
ciation was positive.
The means, standard deviations, and correlations of the POPEQ 
scales with the user involvement scale are displayed in Table 4. 
Correlation analyses showed that the user involvement scale was 
highly correlated with the POPEQ scales ranging from 0.74 (outcome 
of the treatment) to 0.84 (total score) (all Ps < .001).
4  | DISCUSSION
The aim of the current study was to investigate psychiatric outpa-
tients’ perceptions of user involvement after ended treatment, as 
well as demographics and treatment-related predictors of user in-
volvement and the associations of user involvement with treatment 
satisfaction. Results showed that more than half the participants 
reported their overall involvement in their treatment at the outpa-
tient clinic as high or very high. Ratings for user involvement in the 
specific components of treatment were lower than for the perceived 
overall involvement. A scale based on the user involvement items 
showed close associations with user satisfaction regarding the qual-
ity of the interactions with the clinicians, provision of information 
and treatment outcome.
In retrospect, a majority of participants (54.8%) rated the over-
all user involvement in their treatment as high or very high. On 
the other hand, this result means that nearly half the participants 
experienced that they had not at all or, only to some degree, been 
involved in important treatment decisions. This finding is line with 
previous research10,11 and shows that there is room for improvement 
regarding user involvement in psychiatric outpatient treatment de-
spite its emphasis in legal regulations and guidelines. With respect 
to specific areas of user involvement in outpatient treatment, the 
highest percentage of participants who rated their involvement 
as high or very high concerned the formulation of treatment goals 
(47.3%). The formulation of specific and tangible goals is especially 
emphasized in psychological treatments compared with other thera-
peutic approaches (eg medication). Collaboration and consensus on 
treatment goals is an important part of the psychotherapeutic alli-
ance,38 and has been shown to enhance treatment outcomes.39,40 As 
such, agreement on goals is emphasized in different psychotherapy 
approaches.41 Since most patients in the sample received a form of 
psychological treatment, the involvement of patients in the formula-
tion of treatment goals in the present investigation must be consid-
ered low. It can further be argued that the theoretical underpinnings 
of a treatment for psychiatric disorders may influence the level of 
user involvement and that the critical examination of the value base 
of a given approach can contribute to increase user involvement.
Notably, the least endorsed item was sufficient information to 
participate in decision making with 35.6% of participants rating 
this aspect of user involvement as high or very high. Information 
is highly prioritized by patients receiving treatment in medical42 
and mental health settings..43-45 However, patients’ need for in-
formation is often not met.46,47 Crucially, adequate information 
is essential for user involvement.10 The finding of the current 
study that only a third of the participants reported that they had 
received sufficient information to participate in treatment deci-
sions suggests an urgent need to improve the information given 
to the patients. Providing decision aids, that is materials, media 
or interventions that are designed to support patients in the de-
cision-making process48 rather than general information about 
diagnosis and treatment, has shown to be beneficial in terms of 








To a high 
degree
To a very 
high degree
Overall user involvement 2.47 0.99 4.3 11.7 27.1 43.6 11.2
A say in the treatment 
package
2.36 1.10 6.9 11.7 31.9 30.9 14.4
Evaluation of sessions 2.23 1.20 10.1 14.9 27.7 28.7 14.4
Formulation of treatment 
goals
2.32 1.15 7.4 16.0 25.0 33.5 13.8
Termination of treatment 2.05 1.30 17.0 12.8 29.3 21.8 14.9
Sufficient information 2.13 1.10 8.0 18.1 34.6 25.0 10.6
aDue to missing values, the rows do not add to 100%. 
6  |     THIMM eT al.
increased patient knowledge, improved patient-clinician com-
munication, and decreased decision conflict, indecision about 
personal values and passivity.49 In addition to information, Joseph-
Williams et al50 argue that the experience of power imbalance in 
the relationship between the clinician and service user needs to be 
addressed to achieve meaningful user involvement.
In the current sample, the endorsement of involvement in the 
termination of treatment was almost as low as for sufficient informa-
tion to participate in decision making, indicating that the participants 
perceive that the decision about ending the treatment is often made 
by the mental health professional. The assumption that the treat-
ment goals are attained in addition to large caseloads may be bar-
riers to clinicians involving service users in this decision. Although 
patients often agree on termination initiated by the clinician,51 
research suggests that participation in the termination process is 
appreciated by patients and related to experiences of good and pro-
ductive final sessions52 and a stronger therapeutic bond and higher 
satisfaction.51
Results further showed associations of the participants' age, 
gender and educational level with perceived user involvement, 
where younger, female and more highly educated patients report 
more involvement. The effects of gender and education were me-
dium-sized, whereas the effect of age was small based on common 
criteria.34 Previous studies suggest that young, female and educated 
patients prefer a more active role in psychiatric treatment,45,53 
which is in line with the current findings. With regard to treatment 
mode, only training to cope with symptoms was related to user in-
volvement, where patients who received this treatment experienced 
more user involvement than those who did not. Typically, in a train-
ing programme, the therapist and the patient collaborate on design-
ing exercises that are therapeutic and feasible to achieve a specific 
goal (eg anxiety reduction in a phobic situation). Thus, user involve-
ment in this treatment element is usually already firmly established, 
resulting in higher user involvement ratings in the present study. 
Other treatment modes, by contrast, do not differ from each other 
when it comes to perceived user involvement.
The perception of user involvement was strongly connected with 
treatment satisfaction. High correlations suggest that patients who 
experience a high degree of user involvement also tend to rate the 
quality of the interaction with the clinician more favourably, are more 
satisfied with information and have better outcomes. Previous stud-
ies have demonstrated a relationship between user involvement and 
patient satisfaction.54 Findings regarding the associations between 
user involvement and treatment outcomes in psychiatric samples are 
currently inconclusive. There has been noted, however, an associa-
tion when self-report is used and affective-cognitive outcomes are 
assessed.28 The current findings align with this observation.
Taken together, the results of the current study show that user 
involvement in psychiatric outpatient treatment can be improved. 
Interventions aiming at enhancing user involvement should target 
patients, professionals and organizations. The integration of user 
involvement into routine outcome measuring has shown promising 
preliminary results in terms of less conflicts and better outcomes in 
individuals with depression.55 In this effort, it has been suggested 
that drawing on knowledge from implementation science56 and 
established models of factors should be taken into account when 
implementing health innovations (eg implementation climate, imple-
mentation planning and individual characteristics of service provid-
ers).57 More research is needed that focuses on identifying barriers 
to user involvement in the specific aspects of psychiatric outpatient 
treatment on the part of the patients and the clinicians as well on the 
organizational level. Future research should also develop and eval-
uate interventions and aids to facilitate user involvement that are 
specifically tailored to the characteristics of psychiatric outpatient 
treatment.
The present study has some limitations that must be considered 
when interpreting the results. Importantly, causal relationships can-
not be inferred from the results due to the observational and cor-
relational design of the study. For example, it cannot be concluded 
that user involvement has a direct effect on treatment outcome. 
Further, participants were recruited from only one outpatient clinic, 
and the generalizability to other outpatient health services is unclear. 
The generalizability of the current findings is also limited by a rela-
tively low response rate. It was thus not possible to determine how 
TA B L E  3   Results of t tests examining the associations between 
treatment mode and user involvement
Treatment mode M SD t P d
Medication 2.36 0.84 1.01 .315 0.16
No medication 2.21 0.99
Group sessions 2.32 0.87 0.46 .646 0.07
No group sessions 2.25 0.97
Sessions with family 
members
2.22 1.00 −0.23 .818 0.05




to cope with 
symptoms
2.64 0.61 3.45a  >.001 0.50
No training 
programme to cope 
with symptoms
2.18 0.98
aBecause Levene's test for equality of variances was significant (P = .011), 
the t-value for unequal variances is reported. 
TA B L E  4   Descriptives of the POPEQ scales and correlations 
with the user involvement scale total score
POPEQ scale M SD r
Total score 2.69 0.94 0.84*
Quality of clinical 
interaction
2.70 0.96 0.80*
Information provision 2.39 1.19 0.77*
Outcome of the 
treatment
2.80 1.02 0.74*
*P < .001. 
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representative the sample was for the population of the clinic. The 
response rate would probably have been higher if patients were asked 
for participation in the study at discharge. Unfortunately, this was not 
possible due to limited time for the data collection. The recruitment 
of patients who had finished treatment ensured that the participants 
were able to report on their experiences of user involvement for the 
whole course of treatment. On the other hand, we do not know how 
long-term users of the clinic are experiencing their involvement. In 
addition, recall biases can have affected the responses. It is possible 
that patients who were very satisfied or very dissatisfied with the 
treatment were more likely to participate than those in between. 
Similarly, patients’ willingness to participate in the investigation can 
have been influenced by whether discharge was due to treatment 
completion or their decision to terminate the treatment. The sample 
was also highly heterogeneous with respect to diagnoses, resulting 
in relatively few participants who shared the same diagnoses. It was 
therefore not possible to examine the associations between diagno-
sis and perceived user involvement in the sample. User involvement 
was assessed with a scale that was constructed for this investigation, 
and its psychometric properties have not been previously estab-
lished. Patients’ preferences with regard to user involvement were 
not measured. The training of the mental health professionals was not 
assessed, and the associations between perceived user involvement 
and therapist training could therefore not be examined.
In conclusion, the findings of the present study show a mod-
erate degree of perceived user involvement in psychiatric outpa-
tient treatment. Female gender, higher education and, to a small 
degree, younger age were associated with more user involvement. 
Perceived user involvement was strongly associated with treatment 
satisfaction.
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